Physician profile
William Mark Kelley
NPI 1164477105
$980.17
in general payments reported to CMS, 2019-2025
13 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2022: $125 · 2023: $76.21 · 2024: $146 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $231.15 | 2019-2024 | |
| Boston Scientific Corporation | $153.91 | 2024-2025 | General - Biliary Devices |
| Janssen Scientific Affairs, LLC | $125.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $112.99 | 2019 | |
| Ferring Pharmaceuticals INC. | $76.21 | 2023 | Rebyota |
| Janssen Biotech, INC. | $55.08 | 2019 | |
| Ironwood Pharmaceuticals, INC | $43.63 | 2019 | |
| Shionogi INC | $38.28 | 2019 | |
| Braintree Laboratories, INC. | $35.70 | 2019 | |
| Olympus America INC. | $34.72 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.95 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.02 | 2019 | |
| Gilead Sciences, INC. | $15.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.